Literature DB >> 6541985

Immunological responses to complex salts of platinum. II. Enhanced IgE antibody responses to ovalbumin with concurrent administration of platinum salts in the rat.

R D Murdoch, J Pepys.   

Abstract

The effect of platinum group metal salts on IgE antibody synthesis in an animal model was studied with respect to the magnitude and kinetics of the response. In outbred Hooded Lister Rats immunized with 10 micrograms ovalbumin with B. pertussis as adjuvant and boosted with 1 microgram in saline an enhanced secondary response to ovalbumin was obtained when certain halide platinum salts were given concurrently with primary immunization. This phenomenon was limited to ammonium tetrachloroplatinate II, ammonium hexachloroplatinate IV and to a lesser extent the cesium trichloronitroplatinate II. Platinum group metal salts not possessing this characteristic were cis-dichlorodiammine plantinum II, tetra-ammineplatinum II chloride, ammonium aquopentachlororhodate III and ammonium tetrachloropalladate II. Kinetic studies show that the time courses of the primary and secondary responses were not altered in the presence of the platinum salts. In rats immunized with ovalbumin without adjuvant there was no detectable antibody and concurrent administration of platinum salts also had no effects. Thus platinum salts whilst acting synergistically with adjuvant to enhance antibody synthesis do not act as adjuvants in their own right.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541985      PMCID: PMC1577060     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Immediate (type I) allergic responses to platinum compounds.

Authors:  M J Cleare; E G Hughes; B Jacoby; J Pepys
Journal:  Clin Allergy       Date:  1976-03

2.  Rat IgE production. I. Effect of dose of antigen on primary and secondary reaginic antibody responses.

Authors:  E E Jarrett; D C Stewart
Journal:  Immunology       Date:  1974-09       Impact factor: 7.397

3.  Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

Authors:  R J Kociba; S D Sleight
Journal:  Cancer Chemother Rep       Date:  1971-02

4.  Letter: Allergic reactions to cis platinum.

Authors:  D D Von Hoff; M Slavik; F M Muggia
Journal:  Lancet       Date:  1976-01-10       Impact factor: 79.321

5.  Asthma due to inhaled chemical agents--complex salts of platinum.

Authors:  J Pepys; C A Pickering; E G Hughes
Journal:  Clin Allergy       Date:  1972-12

6.  Histamine release by sodium chloroplatinate.

Authors:  A Saindelle; F Ruff
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

7.  Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.

Authors:  A Khan; J M Hill; W Grater; E Loeb; A MacLellan; N Hill
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

8.  Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat.

Authors:  A Prouvost-Danon; A Abadie; C Sapin; H Bazin; P Druet
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Analysis of the serum IgE levels in nonimmunized rats of various strains by a radioimmunoassay.

Authors:  T Karlsson; J R Ellerson; I Dahlbom; H Bennich
Journal:  Scand J Immunol       Date:  1979-03       Impact factor: 3.487

10.  Polyclonal effect of HgCl2 in the rat, its possible role in an experimental autoimmune disease.

Authors:  F Hirsch; J Couderc; C Sapin; G Fournie; P Druet
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

View more
  2 in total

1.  The effect of the castor bean toxin, ricin, on rat IgE and IgG responses.

Authors:  S C Thorpe; R D Murdoch; D M Kemeny
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  Physiological responses to cisplatin using a mouse hypersensitivity model.

Authors:  David M Lehmann; Wanda C Williams
Journal:  Inhal Toxicol       Date:  2020-03-18       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.